call. issued This everyone. XXXX. quarter we press XX, our morning, reporting for our morning, joining results second June Good ended Thank you release a for
during $X the first revenue free cash quarter with the basis. a pleased $X achieved to move continued and and of We Significant QX second generating million closer our revenue We sustained with XXXX consistent of as we XXXX. for on included. of million, our total quarter are financial highlights progress flow profitability
gross the for our is first quarters. QX margin last in highest in gross represents XX.X% sequential from the of improvement XXXX XX margin XX% Our quarter and
natural as the we product our in in channel position to increase #X share our maintain market well. continue and retail BXB to continue We channel important this
on execute a by to softgel acquisition demonstrated continue M&A gels manufacturer. and soft of tincture our as Colorado-based strategy recent We our elevated
continue, on comments and M&A few I the implementation of strategy. our Before a execution
couple actively inbound communicated M&A we have for reviewed years, of numerous have opportunities. and the we last outbound As
are brands, that revenue and our opportunities our for We looking including profitably assets, cost to our distribution. process increase and with leverage increase people efficiency our can transactions and
do One of our achieve so goals top greater and is to scale table.
Another on company position to is major exchange. opportunity an the for to goal major stock list a
be occur, greater to and we have must profitable. scale For this
this making are great progress We front. on
we Over Culture M&A and to acquisition as as profitably. make the have progress revenue The transactions components Foods that last non-EU markets. months, other X EU December XXXX, scale continues strategic well to in completed in the completed increasing marketplace two are
are We products in also the launch in progress U.S. for Foods preparing market. cultured making
We messaging the formulation product have on worked branding, for and U.S. packaging, regulatory compliance, market.
half launch expect to phase of second first We protein during this of the year. products plant-based the
in customer our Our us most of elevated operational provides recent serving softgels brand with owner base. flexibility transaction
minimum and an softgels acquisition FDA-registered capital. further large This efficient and order have production Elevated flexibility current our speed owner of opportunity to of clients facility. greater is able new and non more GMP-certified sales brand with a quantity use customers market creates increase and produce to to development elevated. their product to which are to low new runs, We that provides increases
of and moving further CBD our significant improvement of actively toward in-sourcing our cost efficiency creating plus certain products, also are margin. gross potential We for of production key
CBD to new cash non-CBD growth as QX as products to savings coming and we and cost areas, and a include we with brand QX, of efficiency product organic that flagship to anticipate SG&A. in care efforts Also launch Recent to balance continued numerous well continue And during other the new contribute planning cost will shoes. launches plus operational several the gains continue achieve including efforts throughout overall development XXXX objectives, structure as we pet including our our in products. are of for during efficiency and shoes, other health joint result our product lower hip company our
of Our company. in again, gross a margin to in operating QX demonstrating XX% our cost-efficient commitment improved continuous improvement
us share continue retailers the goal XX% continue retail our our brands of of the In On channel growth are M&A selling the see the continues through the strategy. remove to is scale share, revenue side, market concentration channels top natural Brand product X BXB to as to and through and organic slow-moving help we in our #X brand brands. the increase take company market contraction to range.
loyal to are the and product and we top retail the list at know brands the of are trust, that Customers in natural they channel.
advertising, Our BXC channel spend improve. continuously marketing to and merchandising sales We evaluate our continues BXC return our on investment. optimize to
BXC average in company increased critical channel. and new and orders trust BXC merging good brand investors, value. our KPIs further We that increased seeing We order strong are all brand science will the contraction, including subscription grow in consumer and all believe and education results cannabinoid help
We channel and evolves. grow market category take the to share the prepared are as
Consumers generate that quarter. revenue Product products, multi-active they our like for as be development demanding a our want to trusted. each but be can brands significant claims that carry ingredients continues growth total new important structure portion are sales increasingly CBD high-quality strategy plus a product of function
during line. and line, this addressing several planned and trend over-the-counter have our product and wellness our under Sleep, including and complement products XXXX are products Calm Relief launches topical to We our
and launch and metabolic specific including disorders. states, their are We pain need will continue sleep and that anxiety, for innovate and response customers new products [indiscernible] to
the new our environment trust science challenge claims, and we a of existing supports and regulatory win be the We will that product and to believe continues at state The strong federal and both loyalty our level. customers.
and in and creates can action quality make to and an is advance a cannabis but progress seen the certain legislative need involved to further to while Congress be including FDA way. pushing we and where the in level, trusted frustrating, of products status. hemp regulatory the cannabis progress Incremental Congress industry attention. by progress grow to our Schedule on environment have federal continue possible We responsible states industry states other rescheduling be framework, actively At III a in helps companies in
Our patent remains smokeless methods drug by development treating technology, program. nicotine. and continue countries, believe internally have company to program CBD even drug in development we covers is significant program this value. smokeless this containing partners in collaboration we treatment this formulations of valuable program use pharmaceutical asset. development seek of which though And has XX addiction of a We paused tobacco administering on and tobacco addiction This protected
industry to Our the current compete we environment. are challenges, but has positioning ourselves in
to cost our profitability. We are by streamlining doing growth and operations align and for company the our this increasing efficiency
We have company's in our leverage strengths. a progress made lean, great organization building to positioned cost-efficient is that
has Our that strategy scale to an utilize operational acquire strong M&A efficiency. revenue, allowed platform add our increase operating to us assets and provide
the move X in last just revenue Our and toward will cultured including XXXX recently as add cost line softgels acquisitions December profitability. Foods to efficiency we elevated quarters, and top over promote the
increasing support outbound to cost inbound continue will and plan and We M&A revenues our opportunities that of efficiency. strategic evaluate
will turn I pause call Joerg. the me now Let over and to
